Category: Parry
-
Aphria (APHA.T) ‘Special Committee’ confirms short seller conflict of interest allegations
Several months ago, Aphria (APHA.T) lost a good chunk of its worth when short sellers accused the company executive and board of (in a nutshell) feathering their own nests by agreeing to acquire properties from themselves, for much inflated prices. Today, after a ridiculously long wait which involved the CEO stepping sideways from his position…
-
Dispensing dispensary wisdom: Solo Growth (SOLO.V) plays the long game
In early 2018, Aurora Cannabis (ACB.T) made one of their most interesting asset acquisitions to date, when it bought into the Liquor Stores N.A. chain, snaring 19.9% for $103.5 million. It was the sort of balls out deal Aurora is famous – or infamous, depending on your viewpoint – for, bursting out into a new…
-
Weed company house cleaning: Bonify loses its LP license but grownups are emerging
“We couldn’t be happier to let registered patients know that they can now buy direct from Bonify, a company that truly puts its customers at the core of everything we do,” said company CEO and President Dalbir Bains, back in June 2018, when the company got its Health Canada cannabis sales license. “With the Canadian…
-
SLANG Worldwide (SLNG.C): I have seen the future of cannabis, and this is it
That’s a pretty salesy headline, huh? I mean, I couldn’t have given a higher five to a company in an ultra competitive space with billions in valuations flying around the world than to say, ‘this is the future.’ What I’m suggesting is, one company is on the ultra right path, and not many others are.…
-
Let’s talk weed infrastructure: 3 Sixty Secure Corp (SAFE.C) to debut Tuesday
I’ve not exactly been hiding my opinion that a lot of weed investments right now are overpriced market plays that, when the rubber hits the road, will struggle to do real business. The reasons for that are many, but mostly apply to really big valuations attached to what are really agri plays. If you don’t…
-
TGOD vs Wildflower: Underplaying your hand as opposed to overplaying it
Two news releases wafted past me yesterday that caused me to dig deeper than the words written on the page. This sometimes happens out of necessity – a company has to release news about a topic but can’t go into detail yet, or has bad news they don’t particularly want to run a highlighter over.…
-
Pure Global Cannabis (PURE.V) is up nearly double in a week – and still dirt cheap
When I write about Pure Global (PURE.V), people get confused because a) they’re always down, and b) they’re not a client company. They should be a running joke, right? Like an Instadose or a Namaste (N.V). Well if you bought in when I did, that’s even truer. It hit the markets on opening day around…
-
Instadose: Mistakes were made, but company makes commitment to oversight and improvement
[UPDATE]: The article below is one that we have stood behind from the day we posted it, and do to this day. What it shows is how a young company, one without the oversight of a more mature outfit, can make rash decisions and overpromise in a way that they hope will allow them to…
-
Xmas news dump: Aphria (APHA.T) subject to ‘unfriendly’ takeover by company CEO advises
This Aphria (APHA.T) story just keeps getting richer, and the unbelievable lack of respect this company is giving the market and regulators is a sight to behold. Let’s recap the last few weeks: So now we’re into the dead days of the 2018 market, just after Christmas and right before New Year, when few are…